The relationship between the neutrophil percentage to albumin ratio and the occurrence of prostate cancer
Description
Column Age status: Age ≥60 labeled as "1", otherwise "0"; Column Alcohol Drinking: Non-drinking as "0", low to moderate as "1", heavy drinking as "2"; Column Smoking Status: Never smoked as "1", former smoker as "2", current smoker as "3"; Column Stage: Prostate cancer patients as "1", benign hyperplasia as "0"; Column BMI: <25 kg/m² as "1", 25–30 kg/m² as "2", >30 kg/m² as "3"; Column Hypertension: With hypertension as "1", otherwise "2"; Column Diabetes: With diabetes as "1", otherwise "0"; Column CVD: With cardiovascular disease as "1", otherwise "0"; Column NP: Serum neutrophil percentage; Column Albumin g/L: Serum albumin level; NPAR: Column NP / Column Albumin × 10. Each row represents one patient.
Files
Steps to reproduce
Data were collected retrospectively on serological parameters and routine admission questionnaire data from patients with pathologically confirmed prostate cancer and benign prostatic hyperplasia, prior to their treatment.